RSS-Feed abonnieren
DOI: 10.1055/s-0030-1254153
© Georg Thieme Verlag KG Stuttgart · New York
Characteristics and Clinical Changes during Hospitalization in Bipolar and Psychotic Disorder Patients with versus without Substance-Use Disorders
Publikationsverlauf
received 09.11.2009
revised 21.04.2010
accepted 28.04.2010
Publikationsdatum:
22. Juli 2010 (online)
![](https://www.thieme-connect.de/media/pharmaco/201006/lookinside/thumbnails/10.1055-s-0030-1254153-1.jpg)
Abstract
Background: Co-morbid substance-use disorders (SUDs) are prevalent among patients with severe psychiatric disorders, but the characteristics of such patients remain incompletely defined, and their current treatments and responses, poorly documented.
Methods: We evaluated the records of 481 consecutive inpatients diagnosed with DSM-IV bipolar or schizoaffective disorders, or schizophrenia, admitted to McLean Hospital in 2004 or 2009. Demographic and clinical characteristics, and treatments, were extracted from hospital and pharmacy records for bivariate and multivariate analyses.
Results: SUD prevalence increased 1.84-times from 2004 (31.3%) to 2009 (57.6%). Patients with (n=204) versus without co-morbid SUDs (n=277) were similar in many respects, but in multivariate modeling, the following factors were more likely with SUD, in rank-order: co-morbid anxiety disorders > men more than women > greater prevalence in 2009 vs. 2004 > younger age > greater doses of mood-stabilizers > shorter hospitalization.
Conclusions: Hospitalized patients with severe primary psychiatric disorders, and comorbid SUD were more likely to be young and have anxiety disorders, to receive more combinations and higher doses of mood-stabilizers, and show more improvement in impulsivity and hostility, but otherwise differed little in treatment-responses. Prevalence of SUD rose substantially in the past five years, with increased but largely unproved use of mood-stabilizers.
References
- 1 Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr Scand. 1997; 96 329-333
- 2 Baethge C, Baldessarini RJ, Khalsa HM. et al . Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry. 2005; 162 1008-1010
- 3 Baldessarini RJ, Tarazi FI. Antipsychotic and antimanic agents.. Chapt 18 in Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics, Eleventh Edition. New York: McGraw-Hill; 2005: 461-500
- 4 Baldessarini RJ, Tondo L, Davis P. et al . Decreased risk of suicides and attempts during long-term lithium treatment: meta-analytic review. Bipolar Disord. 2006; 8 625-639
- 5 Bizzarri JV, Rucci P, Sbrana A. et al . Substance use in severe mental illness: self-medication and vulnerability factors. Psychiatry Res. 2009; 165 88-95
- 6 Bradizza CM, Stasiewicz PR. Qualitative analysis of high-risk drug and alcohol use situations among severely mentally ill substance abusers. Addict Behav. 2003; 28 157-169
- 7 Brady KT, Myrick H, Sonne S. Co-occurring addictive and affective disorders.. In Principles of Addiction Medicine, third edition. Graham AW, Schultz TK, Mayo-Smith MF, Graham AW, Schultz TK, Mayo-Smith MF, Ries RK, Wilford BB (eds) Chevy Chase, MD: American Society of Addiction Medicine (ASAM); 2003: 1277-1286
- 8 Brown ES, Perantie DC, Dhanani N. et al . Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study. J Affect Disord. 2006; 93 219-222
- 9 Buckley PF. New antipsychotic agents: emerging clinic profiles. J. Clin. Psychiatry. 1999; 60 12-17
- 10 Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord. 2001; 3 181-188
- 11 Centorrino F, Sani G, Fogarty KV. et al . Combinations of mood-stabilizers with antipsychotics as treatment strategies in hospitalized psychiatric patients. Clin Neuropsychiatry. 2006; 3 322-326
- 12 Dixon L, Haas G, Weiden PJ. et al . Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry. 1991; 48 224-230
- 13 Drake RE, Xie H, McHugo GJ. et al . Effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia Bull. 2000; 26 440-449
- 14 Erkiran M, Ozonalan H, Euren C. et al . Substance abuse amplifies the risk for violence in schizophrenia spectrum disorder. Addict Behav. 2006; 31 1797-1805
- 15 Geller B, Cooper TB, Sun K. et al . Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry. 1998; 37 171-178
- 16 Goldberg JF, Garno JL, Kocsis JH. et al . Correlates of suicidal ideation in disphoric mania. J Affect Disord. 1999a; 56 75-81
- 17 Goldberg JF, Garno JL, Leon AC. et al . History of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry. 1999; 60 733-740
- 18 Goldstein BI, Diamantouros A, Schaffer A. et al . Pharmacotherapy of alcoholism in patients with co-morbid psychiatric disorders. Drugs. 2006; 66 1229-1237
- 19 Green AI. Pharmacotherapy for schizophrenia and co-occurring substance use disorders. Neurotox Res. 2007; 11 33-40
- 20 Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol. 1998; 49 219-224
- 21 Hendrickson EL. Designing, Implementing, and Managing Treatment Services for Individuals with Co-occurring Mental Health and Substance Use Disorders: Blueprints for Action.. Binghamton, NY: Haworth; 2006: 5-40
- 22 Hser H, Grella C, Evans E. et al . Utilization and outcomes of mental health services among patients in drug treatment. J Addict Disord. 2006; 25 73-85
- 23 Kessler RC, Nelson CB, McGonagle KA. et al . The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996; 66 17-31
- 24 Kushner MG, Abrams K, Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev. 2000; 29 149-171
- 25 Mueser KT, Drake RE, Wallach MA. Dual diagnosis: review of etiological theories. Addict Behav. 1998; 23 717-734
- 26 Regier DA, Farmer MD, Rae DS. et al . Co-morbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990; 264 2511-2518
- 27 Rubio G, López-Muñoz F, Alamo C. Effects of lamotrigine in patients with bipolar disorder and alcohol dependence. Bipolar Disord. 2006; 8 289-293
- 28 Salloum IM, Cornelius JR, Daley DC. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: double-blind placebo-controlled study. Arch Gen Psychiatry. 2005; 62 37-45
- 29 Salloum IM, Cornelius JR, Mezzich JE. et al . Impact of concurrent alcohol mis use on symptom presenation of acute mania at initial evaluation. Bipolar Disord. 2002; 4 418-421
- 30 Schofield D, Tennant C, Nash L. et al . Reasons for cannabis use in psychosis. Austral NZ J Psychiatry. 2006; 40 570-574
- 31 Strakowski SM, Keck Jr PE, McElroy SL. et al . Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatry. 1998; 55 49-55
- 32 Swartz MS, Wagner HR, Swanson JW. et al . Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. J Nerv Ment Dis. 2006; 194 164-172
- 33 Tenhula WN, Bennett ME, Strong Kinnaman JE. Behavioral treatment of substance abuse in schizophrenia. J Clin Psychol. 2009; 65 831-841
- 34 Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: four year prospective follow up of 75 patients utilizing survival analysis. Arch Gen Psychiatry. 1990; 47 1106-1111
- 35 Ventriglio A, Vincenti A, Centorrino F. et al . Use of mood-stabilizers for hospitalized adult psychotic and bipolar disorder patients. J Int Clin Psychopharmacol. 2010; in press
- 36 Verheul R. Co-morbidity of personality disorders in individuals with substance use disorders. Eur Psychiatry. 2001; 16 274-282
- 37 Weiss RD, Griffin ML, Jaffee WB. et al . A “community-friendly” version of integrated group therapy for patients with bipolar disorder and substance dependence: randomized controlled trial. Drug Alcohol Depend. 2009; 104 212-219
- 38 Weiss RD, Ostacher MJ, Otto MW. et al . Does recovery from substance use disorder matter in patients with bipolar disorder?. J Clin Psychiatry. 2005; 66 730-735
- 39 Winokur G, Coryell W, Akiskal HS. et al . Alcoholism in manic-depressive (bipolar) illness: familial illness, course of illness, and primary-secondary distinction. Am J Psychiatry. 1995; 152 365-372
- 40 Ziedonis DM, Smelson D, Rosenthal RN. Improving care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract. 2005; 11 315-339
Correspondence
Dr. F. Centorrino
North Belknap 3
McLean Hospital
115 Mill Street
Belmont
MA 02478-9106
USA
Telefon: +1/617/855 2136
Fax: +1/617/855 3826
eMail: fcentorrino@mclean.harvard.edu